Since 2011, we have partnered with biotechnology, biopharmaceutical, and biologics companies of every stage, from early process development through commercial manufacturing.
Mammalian cell culture, downstream purification, and process characterization for mAb manufacturing programs at commercial scale.
Cohn fractionation, human plasma protein extraction, and large molecule recovery from complex source materials.
Bacterial fermentation, viral vector platforms, and recombinant protein expression systems including yeast and microbial.
Process development, technology transfer, and quality systems for emerging cell and gene therapy modalities.